• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病孕妇心脏并发症的危险因素。

Risk Factors of Cardiac Complications in Pregnant Women with Hypertrophic Cardiomyopathy.

机构信息

Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China.

出版信息

Niger J Clin Pract. 2024 Jul 1;27(7):865-872. doi: 10.4103/njcp.njcp_62_24. Epub 2024 Jul 27.

DOI:10.4103/njcp.njcp_62_24
PMID:39082912
Abstract

BACKGROUND

Hypertrophic cardiomyopathy (HCM) is a common inherited genetic cardiac disease during pregnancy. Studies of risk factors are of great significance for maternal and fetal outcomes.

AIM

The aim of the study was to identify predictive risk factors for cardiac complications in pregnant women with HCM.

METHODS

One hundred patients with HCM who delivered at the Shanghai obstetrical cardiology intensive care center between January 2000 and December 2022 were retrospectively reviewed. A logistic regression model was used to identify independent risk factors for cardiac complications.

RESULTS

Twenty-one cases were obstructive HCM (21%), 16 with cardiac function grade I and 5 with grade II; 79 cases were non-obstructive HCM (79%), 67 with cardiac function grade I, 11 with grade II, and 1 with grade III. Ninety-one cases had abnormal electrocardiogram (ECG) (91%), mainly with ST-T changes (77%). The average interventricular septum was 19.39 ± 6.13 mm by echocardiography (21.75 ± 5.86 mm for obstructive HCM and 18.73 ± 6.08 mm for non-obstructive HCM). The main cardiac complications were maternal death (n = 2, 2%), heart failure (n = 7, 7%), and sustained ventricular tachyarrhythmia (n = 1, 1%). Cardiac complications occur commonly during the third trimester and postpartum period. Three independent risk factors to predict cardiac complications in pregnant women with HCM were obstructive HCM (P = 0.036), New York Heart Association (NYHA) class ≥II (P = 0.022), and previous history of syncope (P = 0.037).

CONCLUSIONS

HCM increases the risk of maternal death, heart failure, and malignant arrhythmia. More attention should be given to risk assessment and pregnancy management. Early detection of risk factors can reduce the incidence of maternal mortality and cardiac complications.

摘要

背景

肥厚型心肌病(HCM)是妊娠期间常见的遗传性心脏病。对危险因素的研究对母婴结局具有重要意义。

目的

本研究旨在确定 HCM 孕妇心脏并发症的预测性危险因素。

方法

回顾性分析 2000 年 1 月至 2022 年 12 月在上海产科心脏病重症监护中心分娩的 100 例 HCM 患者。采用 logistic 回归模型识别心脏并发症的独立危险因素。

结果

21 例为梗阻性 HCM(21%),16 例心功能Ⅰ级,5 例心功能Ⅱ级;79 例为非梗阻性 HCM(79%),67 例心功能Ⅰ级,11 例心功能Ⅱ级,1 例心功能Ⅲ级。91 例心电图(ECG)异常(91%),主要表现为 ST-T 改变(77%)。超声心动图显示室间隔平均厚度为 19.39±6.13mm(梗阻性 HCM 为 21.75±5.86mm,非梗阻性 HCM 为 18.73±6.08mm)。主要心脏并发症为孕产妇死亡(n=2,2%)、心力衰竭(n=7,7%)和持续性室性心动过速(n=1,1%)。心脏并发症常见于孕晚期和产后。预测 HCM 孕妇心脏并发症的 3 个独立危险因素为梗阻性 HCM(P=0.036)、纽约心脏协会(NYHA)心功能分级≥Ⅱ级(P=0.022)和晕厥史(P=0.037)。

结论

HCM 增加了孕产妇死亡、心力衰竭和恶性心律失常的风险。应更加重视风险评估和妊娠管理。早期发现危险因素可降低孕产妇死亡率和心脏并发症的发生率。

相似文献

1
Risk Factors of Cardiac Complications in Pregnant Women with Hypertrophic Cardiomyopathy.肥厚型心肌病孕妇心脏并发症的危险因素。
Niger J Clin Pract. 2024 Jul 1;27(7):865-872. doi: 10.4103/njcp.njcp_62_24. Epub 2024 Jul 27.
2
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags.肥厚型心肌病:疾病特异性警示信号的患病率
Eur Heart J. 2025 Aug 14;46(31):3082-3094. doi: 10.1093/eurheartj/ehaf026.
3
Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach.利用心电图识别肥厚型心肌病的高危影像学特征:深度学习方法。
Heart Rhythm. 2024 Aug;21(8):1390-1397. doi: 10.1016/j.hrthm.2024.01.031. Epub 2024 Jan 26.
4
[Prevalence of ECG abnormalities in hypertrophic cardiomyopathy: who seeks will find].肥厚型心肌病中心电图异常的患病率:有心者必能发现
Orv Hetil. 2025 Jun 22;166(25):970-981. doi: 10.1556/650.2025.33289.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.儿童 RAS 相关肥厚型心肌病中的心源性猝死:HCM 风险儿童模型的验证和事件预测因子。
Int J Cardiol. 2023 Dec 15;393:131405. doi: 10.1016/j.ijcard.2023.131405. Epub 2023 Sep 28.
7
Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5 Years.重新审视丙吡胺治疗有症状的梗阻性肥厚型心肌病:至少治疗5年患者的疗效和安全性
J Am Heart Assoc. 2025 Jan 21;14(2):e037639. doi: 10.1161/JAHA.124.037639. Epub 2025 Jan 16.
8
Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).足月(37周及以上)胎膜早破时计划早产与期待治疗(等待)的比较。
Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD005302. doi: 10.1002/14651858.CD005302.pub3.
9
Distance Between the Anterior Papillary Muscle and Interventricular Septum Evaluated by Echocardiography to Diagnose Midventricular Obstruction in Hypertrophic Cardiomyopathy.经超声心动图评估前乳头肌与室间隔之间的距离以诊断肥厚型心肌病的心室中部梗阻
J Am Soc Echocardiogr. 2025 Aug;38(8):698-709. doi: 10.1016/j.echo.2025.04.018. Epub 2025 May 6.
10
Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research.妊娠期和产褥期的血栓预防:一项系统评价和经济评估,以估算未来研究的价值。
Health Technol Assess. 2024 Mar;28(9):1-176. doi: 10.3310/DFWT3873.

引用本文的文献

1
Sailing Across Contraception, Pregnancy, and Breastfeeding: The Complex Journey of Women with Cardiomyopathies.跨越避孕、妊娠和母乳喂养:心肌病女性的复杂历程
J Clin Med. 2025 Jul 14;14(14):4977. doi: 10.3390/jcm14144977.